Vikas Multicorp Ltd. to Enter Pharma and Healthcare Business; Board in Principally Approves Acquisition
| Wednesday | 13th January, 2021
BSE and NSE listed Vikas Multicorp Ltd. had recently announced the outcome of its Board meeting held on 12 January, 2021.
Advik Laboratories has an established infrastructure facility to manufacture quality pharmaceuticals for both, domestic and export markets.
The company, Advik, has been supplying Pharma products to large Indian Pharma companies like Dr. Reddy Laboratories Ltd., Cadila Pharmaceuticals Ltd., Abbott India Ltd. and Torrent Pharmaceuticals Ltd., etc.
The company is taking another forward stride with its Board’s in principal approval of Advik Laboratories Ltd. acquisition.
Over the last few months, Albula Investment Fund, LTS Investment Fund, and Alintosch Pharma (Baidyanath group) have all picked up stake in Vikas Multicorp Ltd.